In the next 5 years, the market is expected to grow to $105 billion, representing a 17.5x increase in market value: By 2030, the US GLP-1 patient pool will include 15 million people, representing 9% of Americans with diet-related diseases
Walk into a health food store or shop that sells vitamins and supplements, or browse online, and youll find a number of supplements that might be worth a second look
In addition, when the glucose level in the blood falls, it makes the person feel hungry and lethargic
All these research findings dont imply GLP-1s arent valuable products
Cross-reference at least two review sources
Medicare Part D doesnt cover the drugs for obesity unless a patient also has a comorbidity such as cardiovascular disease as well the very problem Wegovy or Ozempic can prevent